About NIAID

Strategic Plan 2000
NIAID: Planning for the 21st Century

Appendix B
NIAID Council Members

Jorge L. Benach, Ph.D., is professor of microbiology and pathology at the State University of New York at Stony Brook where he is also director of the Infectious Diseases Institute of the Center for Molecular Medicine. A co-discoverer of the etiologic agent of Lyme disease, his research interests have centered on the pathogenesis of spirochetal and other tick-borne infections. Dr. Benach has served on Public Health Service advisory committees, including two NIH study sections, and on the editorial boards of several journals.

Kim Bottomly, Ph.D., is professor of immunobiology and dermatology, Yale University School of Medicine. Dr. Bottomly was a member of the Immunobiology Study Section and has served on several committees of the American Association of Immunologists. Her research focuses on the factors that regulate CD4 + T-cell differentiation and function. Dr. Bottomly's recent studies are building on her research findings in this area to broaden understanding of the role of CD4 + T cells in the pathogenesis of asthma.

Robert B. Couch, M.D., is professor and chairman, Department of Microbiology and Immunology, and professor of medicine, Baylor College of Medicine. He has served on many advisory committees, including an NIH study section, NIAID Board of Scientific Counselors, National Vaccine Advisory Committee, and the FDA Vaccines and Related Biological Products Advisory Committee. Dr. Couch was an associate editor of research journals and a microbiology textbook. His research has focused on acute respiratory diseases, particularly influenza and rhinoviruses, and vaccine development.

Lawrence Deyton, M.S.P.H., M.D., is director of HIV/AIDS services and research for the Department of Veterans Affairs. Dr. Deyton's interests are HIV clinical research and strategies of HIV treatment. He served in several positions in NIAID between 1987 and 1998: acting director of the Division of Extramural Activities, chief of the HIV Research Branch, and chief of the Community Clinical Research Branch in DAIDS and was a fellow in infectious diseases in NIAID's Laboratory of Immunoregulation.

Jerrold J. Ellner, M.D.,* is professor and executive vice chair, Department of Medicine, Case Western Reserve University and University Hospitals, Cleveland, He is also co- chair, Tuberculosis and Leprosy Panel, U.S.-Japan Cooperative Medical Sciences Program, member of the Immunology of Mycobacterial Diseases Steering Committee, WHO, and director, Tuberculosis Research Unit, Case Western Reserve University. Dr. Ellner has served on many advisory committees, including the Advisory Council for Elimination of Tuberculosis, and was a member and chair of the Bacteriology and Mycology-1 Study Section.

Lt. Col. Theodore M. Freeman, M.D., is chairman, Department of Allergy/Immunology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas. A member of the U.S. Air Force, he is program director for the Allergy/Immunology Fellowship Program and Clinical Laboratory Immunology Fellowship Program and medical co-director of the Clinical Immunology Laboratory, which includes the transplantation lab section at Wilford Hall Medical Center. His research has focused primarily on environmentally related allergy topics, specifically medical aspects of the imported fire ant.

Raif S. Geha, M.D., is a professor of pediatrics at Harvard Medical School and Chief of Immunology at Children's Hospital, Boston. Dr. Geha's long-standing research interest is in the molecular basis of IgE synthesis and primary immunodeficiencies. His work examines the roles of CD40 signaling in isotype switching, SLP-76 in the function of hematopoietic cells, the Wiskott Aldrich protein in cytoskeletal reorganization, and skin injury in atopic sensitization.

Janis V. Giorgi, Ph.D., is professor of medicine, UCLA School of Medicine, and director, UCLA Research Core Flow Cytometry Facility, Jonsson Comprehensive Cancer Center, and the Center for AIDS Research. Dr. Giorgi studies AIDS immunology and has published on immunophenotypic and functional alterations of HIV-1 disease. Her research is directed at identifying mechanisms of host protective immunity against viral infection and pathogenesis. She is active in developing clinical immunology, especially applications of flow cytometry in the diagnosis and prognosis of disease.

Ellen H. Goldberg, Ph.D., is president, Santa Fe Institute, and research professor of biology, Department of Microbiology, University of New Mexico School of Medicine, previously serving as chair of microbiology and associate provost of research and dean of graduate studies. Dr. Goldberg has participated on NIH study sections and the National Task Force on the NIH Strategic Plan. She is past chair, Immunology Division, American Society for Microbiology, and fellow of the Academy of Microbiologists. Dr. Goldberg's research focuses on differentiation antigens.

Barton F. Haynes, M.D., is the Frederic M. Hanes professor and chair, Department of Medicine, and director of the Human Vaccine Institute at Duke University. Dr. Haynes studies the biology of the human thymus and is currently exploring ways to reconstitute the immune system in HIV infection. Dr. Haynes also guides an HIV vaccine program to design adjuvants and immunogens to induce protective immune responses to HIV.

James M. Hughes, M.D., is the director of the National Center for Infectious Diseases of the Centers for Disease Control and Prevention. Dr. Hughes has published on many infectious disease topics, including the epidemiology and pathogenesis of enteric diseases and the epidemiology, surveillance, and control of nosocomial and emerging infections.

William R. Jacobs, Jr., Ph.D.,** is professor in the Departments of Microbiology and Immunology and Molecular Genetics at Albert Einstein College of Medicine (AECOM) and investigator in the Howard Hughes Medical Institute. Dr. Jacobs studies mycobacteria and has made significant contributions in identifying the mechanisms of action of the mycobacterial drugs isonaizid and ethionamide as well as novel factors of M. tuberculosis required for growth and persistence in vivo. He has authored more than 75 original publications on mycobacteria and numerous reviews.

Warren D. Johnson, Jr., M.D.,* is the B.H. Kean professor of tropical medicine and chief, Division of International Medicine and Infectious Diseases, Cornell University Medical College. He is a director of the American Board of Internal Medicine and chair of the Subspecialty Board on Infectious Diseases. He has served on numerous other committees, including chair of the NIAID Microbiology and Infectious Diseases Review Committee. Dr. Johnson's research interests include the epidemiology, pathogenesis, and therapy of parasitic diseases, HIV infection, and tuberculosis.

Richard A. Koup, M.D.,** is the Jay P. Sanford professor of infectious diseases and chief, Division of Infectious Diseases, the University of Texas Southwestern Medical Center. Dr. Koup's research interests include the immunopathogenesis of HIV, cellular immunity to HIV, the role of the thymus in immune reconstitution, and co-receptors in HIV entry. Dr. Koup has served on NIH study sections, the NIAID Strategic Plan Task Force, and as a scientific advisor to academic HIV research centers.

Thomas J. Lawley, M.D., is dean and William P. Timmie professor of dermatology, Emory University School of Medicine, as well as vice president of Emory Healthcare and president of Emory Medical Care Foundation. Dr. Lawley is the former chair of dermatology at Emory. His areas of research interest include autoimmune skin diseases, the cell biology of endothelial cells, and regulation of cell adhesion molecules. Dr. Lawley has served on many boards and committees, including NIH study sections.

Stephan E. Lawton, J.D., is a lawyer in private practice, representing medical specialty organizations, and public health associations. These organizations include the American Academy of Pediatrics, the Infectious Diseases Society of America, the American Cancer Society, and the Endocrine Society. Mr. Lawton has also worked on Capitol Hill developing legislation in health-related areas, and was recently chairman of the PHS Advisory Commission on Childhood Vaccines.

Garry T. Lyle* is vice president, Public Sector Customer Business Center, the Xerox Corporation, St. Petersburg, Florida. Mr. Lyle is a former athlete with the Chicago Bears (1967 to 1974). In his 20 years of experience working in business operations, Mr. Lyle's management focus has included logistics and distribution, profit and loss, audit readiness control, and customer service. He is an active member of Family Resources, Inc., serving on its board and on several other committees.

John C. Martin, Ph.D.,** is the president and chief executive officer of Gilead Sciences, Inc. Previously, he was employed at Bristol-Myers Squibb and at Syntax Corporation where he was the co-inventor of ganciclovir. He is president of the International Society for Antiviral Research and received the Isbell Award of the American Chemical Society for his applications of carbohydrate chemistry to the design of medicinally active nucleosides and nucleotides.

Paula M. Pitha-Rowe, Ph.D.,* is professor at the Johns Hopkins Oncology Center and the Department of Molecular Biology and Genetics and is associate director for basic research training at the Johns Hopkins University School of Medicine, Baltimore. Her research focuses on the interferon system, interactions between HIV-1 and host cells, and the regulation of expression of early inflammatory genes in infected cells. Dr. Pitha-Rowe has served on NIH study sections and is a member of the FDA Advisory Group on Biological Modifiers.

Marie M. Saint Cyr, M.S.W., is the executive director of Iris House, the first and only comprehensive program for women living with HIV/AIDS and their families. She serves as an appointee of Mayor Guiliani as community co-chair of the HIV Planning Council of New York City. She is also chairperson of the board of the National Minority AIDS Council in Washington, D.C., and serves on local advisory boards. Ms. Saint Cyr has been a fervent advocate for people with AIDS and their families since 1984, helping to bring resources to the communities in dire need of help.

Magdalene So, Ph.D.,** is professor and chair of the Department of Molecular Microbiology and Immunology at the Oregon Health Sciences University. She has served on the Bacteriology and Mycology 1 study section and a number of other NIH panels. She is presently serving on the editorial boards of several scientific journals and as vice chair of the Committee on Conferences of the American Society of Microbiology. Her research focuses on the pathogenic Neisseriae, in particular, the genetic, cellular, and biochemical events that mediate bacterial adhesion, entry, and trans-epithelial migration.

Emily J. Spitzer, J.D., is the immediate past chair of research for the Juvenile Diabetes Foundation International. In addition to serving on its International Board of Directors, she has participated in the organization's grant review process for the past 7 years and has also served on its Government Relations Committee helping to formulate strategies to encourage more biomedical research not only in the public sector but also in partnership between public and private organizations.

Gary Tarpley, Ph.D.,* is vice president, discovery research, Pharmacia & Upjohn, Inc., Kalamazoo. Dr. Tarpley's research interests include the expression of essential HIV genes and analyses of the structure and function of critical HIV proteins, molecular retrovirology, the molecular mechanisms of viral drug resistance, the molecular mechanisms involved in the transformation of animal cells, the structure and function of oncogenes, and molecular targets for the discovery of cancer drugs.

Thelma King Thiel, R.N., B.A.,** is the founder, voluntary chair, and chief executive officer of the Hepatitis Foundation International. She has served on the National Commission on Digestive Diseases, the National Digestive Diseases Advisory Board, as president and chief operating officer of the American Liver Foundation, and as chair of the Digestive Diseases National Coalition and is a fervent participant in numerous patient advocacy organizations. Following the loss of an infant son to a rare liver disease 30 years ago, she created a "liver character," developed unique liver wellness and preventive education programs and materials, lectured extensively, published articles, and was featured in a PBS Documentary, The Visionaries.

Emil R. Unanue, M.D., is professor of pathology and head, Department of Pathology and the Center for Immunology, Washington University School of Medicine. He has served on NIH advisory committees, most recently the NIAID Board of Scientific Counselors. Dr. Unanue's long-standing interest is the biology and molecular understanding of antigen processing and presentation. His work examines the biochemical basis of peptide presentation by class II histocompatibility molecules, including autologous peptides involved in autoimmune diabetes, and innate immune responses to intracellular pathogenic bacteria.

Lowell S. Young, M.D., is director, Kuzell Institute for Arthritis and Infectious Diseases, and clinical professor of medicine, University of California San Francisco. Dr. Young's research includes basic investigation of bacterial pathogenesis and treatment of opportunistic infections especially in immunocompromised hosts. He is editor of Antimicrobial Agents and Chemotherapy and an author of more than 300 research papers and book chapters. Dr. Young has received the Langmuir Prize from CDC and the Garrod Medal of the British Society for Antimicrobial Chemotherapy.

back to top